Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT
Sponsor: Prince of Songkla University
Summary
To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.
Official title: Efficacy and Safety of Intracameral Versus Intravitreal Bevacizumab Injection as an Adjunctive Therapy Before Trabeculectomy With Mitomycin-C in Neovascular Glaucoma: A Prospective Randomized Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2018-08-01
Completion Date
2026-07-01
Last Updated
2025-08-21
Healthy Volunteers
No
Interventions
Intracameral injection
A/C injection of 1.25 mg/0.05 mL bevacizumab
Intravitreal injection
Vitreous injection of 1.25 mg/0.05 mL bevacizumab
Locations (1)
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand